WADA to provide education on the Athlete Biological Passport. WADA

The World Anti-Doping Agency (WADA) is providing an update on the development and implementation of new features of the Athlete Biological Passport and announcing related webinars to be held on 12 and 19 June 2024.

WADA would like to update stakeholders on the progress of the Athlete Biological Passport (ABP) following the launch of the Endocrine Module and Blood Steroid Markers in the Steroid Module in 2023, and their integration into a new ABP interface in WADA's Anti-Doping Administration Management System (ADAMS) NextGen.

To provide further updates andpractical guidance on the new ABP modules, WADA will conduct two webinars.

The first webinar will focus on optimising the use of the ABP interface in ADAMS NextGen, covering basic account setup and athlete group management for less experienced users (12 June).

The second webinar will focus on practical considerations for integrating these features into an overall testing strategy for Anti-Doping Organisations (ADOs) (19 June).

The launch of the new Endocrine Module introduced the ABP's ability to detect the abuse of Human Growth Hormone (hGH) and related compounds. This detection method can identify abnormalities below the previous population-based thresholds of the hGH biomarker test, aiding in the selection of samples for further hGH analysis and ultimately improving the identification of suspected athletes. Several National Federations have already used this tool in preparation for the Paris 2024 Games.

In addition to the existing urinary steroid profile, the new blood steroid markers provide a more immediate snapshot of steroid levels prior to metabolism and excretion in urine.

The blood steroid profile has helped to identify urine samples positive for testosterone that were not flagged by the urinary steroid profile. 

It has also helped to identify normal blood steroid profiles in some cases of athletes with long-standing variable urine profiles, allowing Anti-Doping Organisations to allocate resources elsewhere. Blood steroid markers have also improved the detection of steroid abuse in population groups with known low urinary steroid levels, including women and Asian populations.

The upcoming webinars, which require pre-registration, will be held on 12 June at 10:00 EDTand will focus on optimising the use of the Athlete Biological Passport (ABP) module in ADAMS NextGen, and on19 June at 10:00 EDTand will focus on practical considerations for maximising the use of the new ABP functionality.